Randomized Controlled Trials Assessing Continuous Outcomes for the use of Platelet-Rich Plasma in Knee Osteoarthritis Are Statistically Fragile: A Systematic Review.
Darius L Lameire, Hassaan Abdel Khalik, Praveen Sritharan, Varun Jain, Alan Cheng, Moin Khan, Jaskarndip Chahal
{"title":"Randomized Controlled Trials Assessing Continuous Outcomes for the use of Platelet-Rich Plasma in Knee Osteoarthritis Are Statistically Fragile: A Systematic Review.","authors":"Darius L Lameire, Hassaan Abdel Khalik, Praveen Sritharan, Varun Jain, Alan Cheng, Moin Khan, Jaskarndip Chahal","doi":"10.1016/j.arthro.2024.09.054","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study is to assess the statistical fragility of randomized controlled trials that assess the use of platelet rich plasma (PRP) for the treatment of knee osteoarthritis (OA) and report a continuous primary outcome measure with statistical significance.</p><p><strong>Methods: </strong>A systematic electronic search of MEDLINE, EMBASE, and Cochrane database was performed on July 26, 2023. All randomized controlled trials addressing the use of PRP for the treatment of symptomatic knee osteoarthritis were included that reported statistically significant primary continuous outcomes. The continuous fragility index (CFI) and continuous fragility quotient (CFQ) was calculated using approximative method as previously described using the mean and standard deviation of the outcomes of interest.</p><p><strong>Results: </strong>There was a total of 34 eligible outcomes for analysis. The overall median CFI across all included studies was 5.7 (IQR, 4.8 - 9.9). The overall median CFQ across all included studies was 0.131 (IQR, 0.055 - 0.243). Loss to follow-up was greater than the CFI in only 3 of 34 eligible outcomes (8.8%). The most analyzed outcome was the WOMAC total score (n=9) with a median CFI of 6.6 and median CFQ of 0.250. The outcome with the highest median CFI was the WOMAC stiffness subscale at 93. Spearman correlation analysis demonstrated a non-statistically significant trend towards decreasing CFI (-0.497) and a statistically significant decrease in CFQ (-0.681, p = 0.03) with increasing grades of osteoarthritis.</p><p><strong>Conclusion: </strong>The was an overall median CFI of 5.7 and CFQ of 0.131 for RCTs that report statistically significant continuous outcomes for the use of PRP for symptomatic knee OA. Although there are no current guidelines regarding statistical fragility of continuous outcomes, these results can be considered fragile given statistical significance may be reversed with only a few changes in patient outcomes.</p><p><strong>Level of evidence: </strong>2; systematic review of Level I and II studies.</p>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arthro.2024.09.054","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: The aim of this study is to assess the statistical fragility of randomized controlled trials that assess the use of platelet rich plasma (PRP) for the treatment of knee osteoarthritis (OA) and report a continuous primary outcome measure with statistical significance.
Methods: A systematic electronic search of MEDLINE, EMBASE, and Cochrane database was performed on July 26, 2023. All randomized controlled trials addressing the use of PRP for the treatment of symptomatic knee osteoarthritis were included that reported statistically significant primary continuous outcomes. The continuous fragility index (CFI) and continuous fragility quotient (CFQ) was calculated using approximative method as previously described using the mean and standard deviation of the outcomes of interest.
Results: There was a total of 34 eligible outcomes for analysis. The overall median CFI across all included studies was 5.7 (IQR, 4.8 - 9.9). The overall median CFQ across all included studies was 0.131 (IQR, 0.055 - 0.243). Loss to follow-up was greater than the CFI in only 3 of 34 eligible outcomes (8.8%). The most analyzed outcome was the WOMAC total score (n=9) with a median CFI of 6.6 and median CFQ of 0.250. The outcome with the highest median CFI was the WOMAC stiffness subscale at 93. Spearman correlation analysis demonstrated a non-statistically significant trend towards decreasing CFI (-0.497) and a statistically significant decrease in CFQ (-0.681, p = 0.03) with increasing grades of osteoarthritis.
Conclusion: The was an overall median CFI of 5.7 and CFQ of 0.131 for RCTs that report statistically significant continuous outcomes for the use of PRP for symptomatic knee OA. Although there are no current guidelines regarding statistical fragility of continuous outcomes, these results can be considered fragile given statistical significance may be reversed with only a few changes in patient outcomes.
Level of evidence: 2; systematic review of Level I and II studies.
期刊介绍：
Nowhere is minimally invasive surgery explained better than in Arthroscopy, the leading peer-reviewed journal in the field. Every issue enables you to put into perspective the usefulness of the various emerging arthroscopic techniques. The advantages and disadvantages of these methods -- along with their applications in various situations -- are discussed in relation to their efficiency, efficacy and cost benefit. As a special incentive, paid subscribers also receive access to the journal expanded website.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
